19
1
49
7
8
a
1b
1d
18
89
34
1d
2 29
1d
25
34
Emily Baumrin, MD, MSCE
79Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
7
62
Department: Dermatology
4
1
b
1d
46
Contact information
49
4
3
3
1d
49
3400 Civic Center Boulevard
60 Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
26
60 Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
30
Office: (215)-614-0700
30
f
30
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 7 BA 19 (Biochemistry) c
2a Dartmouth College, 2010.
21 7 MD 15 (Medicine) c
50 University of Pennsylvania, Perelman School of Medicine, 2015.
21 9 MSCE 19 (Epidemiology) c
33 University of Pennsylvania, 2023.
c
3
27
21 7 BA 19 (Biochemistry) c
2a Dartmouth College, 2010.
21 7 MD 15 (Medicine) c
50 University of Pennsylvania, Perelman School of Medicine, 2015.
21 9 MSCE 19 (Epidemiology) c
33 University of Pennsylvania, 2023.
c
Links
b7 Search PubMed for articles
d
5
3
3
8d
Permanent linkb7 Search PubMed for articles
d
2 29
21
1e
1d
24
7
29
27
23
f8 Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S: Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood 145(12): 1321-332, Mar 2025.
130 Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J: Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 161(3): 281-90, Mar 2025.
114 Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E: Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease. Am J Dermatopathol 46(11): 755-60, Nov 2024.
139 Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S: Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv 8(17): 4651-657, Sep 2024.
160 Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J: Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy. JAMA Dermatol 160(7): 741-45, Jul 2024.
10f Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J: Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 160(4): 393-401, Apr 2024.
115 Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E: Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther 30(3): 338, Mar 2024.
1d3 Mital R, Otto T, Savu A, Baumrin E, Cardones A, Carlesimo M, Caro G, Freites-Martinez A, Hirner J, Markova A, McLellan B, Rossi A, Sauder M, Seminario-Vidal L, Sibaud V, Owen D, Dulmage B, Chen S, Kaffenberger B: Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol 62(8): 1020-25, Aug 2023.
166 Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, Jurdi NE, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER: Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatol 159(4): 393-402, Apr 2023.
2c
7
1d
1f
Selected Publications
15c Lazarow H, Carulli A, McWilliams T, Kucharczuk C, Hollander L, Catania C, Munshi P, Gabriel P, Loren A, Porter D, Baumrin E: Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period. Support Care Cancer 33: 755, Aug 2025.f8 Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S: Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood 145(12): 1321-332, Mar 2025.
130 Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J: Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 161(3): 281-90, Mar 2025.
114 Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E: Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease. Am J Dermatopathol 46(11): 755-60, Nov 2024.
139 Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S: Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv 8(17): 4651-657, Sep 2024.
160 Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J: Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy. JAMA Dermatol 160(7): 741-45, Jul 2024.
10f Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J: Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 160(4): 393-401, Apr 2024.
115 Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E: Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther 30(3): 338, Mar 2024.
1d3 Mital R, Otto T, Savu A, Baumrin E, Cardones A, Carlesimo M, Caro G, Freites-Martinez A, Hirner J, Markova A, McLellan B, Rossi A, Sauder M, Seminario-Vidal L, Sibaud V, Owen D, Dulmage B, Chen S, Kaffenberger B: Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol 62(8): 1020-25, Aug 2023.
166 Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, Jurdi NE, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER: Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatol 159(4): 393-402, Apr 2023.
2c